Skip to main content

Peptide Care

PEPTIDES, WITHOUT THE HYPE.

Lemonaid is exploring clinician-guided peptide care. Join the waitlist for plain-English education, updates on what we're evaluating, and early access if and when new peptide options become available.

Get in line
Illustration of a sealed clear glass vial with a dark green label beside a cream envelope sealed with a green dot
Flat illustration of a smiling clinician at a desk writing in an open notebook, with a laptop chart, glasses, plant and mug

Curious about peptides? So are a lot of people.

There's no shortage of peptide information online. What's harder to find is clear, responsible guidance about what the science actually says.

That's where we come in.

We're following the research, evaluating potential treatment options, and working to make peptide care easier to understand—without promises the evidence can't support.

Areas Worth Exploring

Peptides aren't one treatment—and the research isn't the same for every peptide. We're evaluating potential options across several areas of health and wellness.

  • Metabolic Health

    Research evolving · under study

  • Recovery & Tissue Repair

    Research evolving · under study

  • Sleep

    Research evolving · under study

  • Skin & Collagen

    Research evolving · under study

  • Lean Mass

    Research evolving · under study

  • Cognitive Focus

    Research evolving · under study

What are Peptides?

Different peptides interact with different biological pathways, which is why researchers are studying them across areas ranging from metabolism and recovery to skin, sleep, and more.

But “peptides” isn't one treatment category with one set of benefits. The evidence, potential uses, risks, and regulatory status can vary significantly from one peptide to another.

That's why we're looking at each one individually.

The Peptide Pledge

IF WE OFFER IT, WE NEED TO UNDERSTAND IT.

Our approach to peptide care is simple:

  • Evidence before hype. - We'll look at what the research actually supports.
  • Clear sourcing and standards. We'll be transparent about what work care works.
  • Straight answers. - No miracle language. No making early research sound like established medicine.
Get in line

Explore Popular Peptides

There's a lot of conversation around emerging peptides. Here are some of the compounds we're following as the research and regulatory landscape continue to develop.

BPC-157 — Research related to digestive health and tissue repair

BPC-157 is currently studied for its potential role in gastrointestinal health and tissue repair. Originally isolated from gastric juice in 1993 by Dr. Predrag Sikiric, BPC-157 has demonstrated regenerative properties in animal models, promoting the healing of tendons, ligaments, muscles, nerves, and bones. Due to its potential musculoskeletal benefits, including injury prevention, enhanced exercise recovery, and tissue repair, BPC-157 has gained anecdotal popularity among athletes, with increasing reports of its use in sports and fitness communities.*

Reference: https://pmc.ncbi.nlm.nih.gov/articles/PMC12446177/ https://pmc.ncbi.nlm.nih.gov/articles/PMC11859134/

KPV — Research related to inflammatory response / gut health

KPV is a tripeptide (Lys-Pro-Val) which possesses anti-inflammatory properties. This peptide is being studied for its potential interaction with inflammatory pathways. Early research has explored KPV in areas such as gut health.*

Reference: https://pmc.ncbi.nlm.nih.gov/articles/PMC2431115/ https://academic.oup.com/jleukbio/article-abstract/67/2/233/6926759?login=false https://pmc.ncbi.nlm.nih.gov/articles/PMC5498804/

TB-500 — Research related to tissue repair and recovery

TB-500 is being studied for its potential role in wound-healing and tissue-repair processes. This peptide is gaining interest from athletes and fitness enthusiasts. Research has shown its potential to promote soft-tissue and muscle regeneration.* The body naturally produces the protein Thymosin Beta-4; TB-500 is a synthetic fragment of Thymosin Beta-4. At times this peptide is used alongside BPC-157.

Reference: https://pubmed.ncbi.nlm.nih.gov/23084823/

MOTS-c — Research related to metabolism, weight management and cellular energy

MOTS-c is a mitochondrial-derived peptide being studied for its relationship to cellular energy, metabolism, exercise and age-related health. It may be of interest to people exploring research related to metabolic health and healthy aging.*

Reference: https://pmc.ncbi.nlm.nih.gov/articles/PMC9905433/

Want to know what's next?

Join the Lemonaid peptide waitlist.

We'll keep you updated as we evaluate potential peptide offerings, share educational information, and prepare for future program launches.


Joining the waitlist may include:

  • Updates about peptide care at Lemonaid

  • Educational content about peptides we're evaluating

  • News about future availability

  • Opportunities to learn more as programs develop

Joining the waitlist does not mean you've been approved for treatment. Any future treatment would depend on availability, applicable requirements, and evaluation by a licensed healthcare provider.

May we send you text message updates?

You'll get plain-English education and first word when we can offer peptides. Unsubscribe anytime.

Man is researching peptide topics while enjoying coffee and breakfast

FAQs: Questions about peptide care

Are these peptides available through Lemonaid Health today?

No. Lemonaid Health is excited for the research being done and will make sure you are the first to know if anything changes. Join the waitlist to receive updates, education, and any new services as they become available.

Does joining the waitlist mean I qualify for treatment?

No. Joining the waitlist does not guarantee access to any treatment. Eligibility for our services is determined by a licensed medical provider based on your health information, applicable regulations and the treatments available.

Are these peptides FDA-approved?

No. BPC-157, KPV, TB-500 and MOTS-c are not FDA-approved drugs. The regulatory status of pharmacy compounding with these substances is currently under FDA review.

Are compounded medications FDA-approved?

No. Compounded drugs are not FDA-approved, which means the FDA does not review or verify their safety, effectiveness or quality before they are marketed.